MarketCapExport financials
Welltower (WELL)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Welltower Financial Ratios 2025-2007 | WELL
Brief overview of Welltower 's multiples and efficiency
Ratios are assessed across five available annual reports in the 2021–2025 interval.
The current valuation set is P/E 145.32x (median 134.52x), EV/EBITDA 48.66x (median 28.63x), P/S 12.9x (median 7.41x). The current ratio basket stands about 70% above the five-year base, increasing sensitivity to weak reports.
Current earnings relative to valuation equal about 0.7% on the 1/P/E measure. This is a valuation reference, not an expected payout.
Capital efficiency is characterized by ROE 2.3%, ROA 1.4%, ROCE 2.2%. Business quality is below comfortable levels on current returns. Better margins or turnover are needed.
The cash return period is stable at 17.9 days initially and 8 days at the end.
Overall picture
Welltower 's multiples are demanding relative to current business quality. Material improvement is needed to justify them.
Annual Financial Ratios Welltower
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
149.2 | 93.2 | 141.7 | 250.6 | 93.8 | 26.1 | 27.8 | 35.6 | 41.1 | 22.1 | 24.5 | 49.0 | 108.9 | 47.6 | 45.4 | 42.1 | 20.6 | 15.9 | - |
P/S |
12.9 | 11.1 | 7.3 | 6.0 | 7.4 | 5.9 | 6.7 | 6.1 | 5.0 | 5.6 | 5.6 | 7.5 | 5.5 | 7.8 | 6.9 | 9.5 | 8.4 | 9.2 | - |
EPS |
1.4 | 1.6 | 0.7 | 0.3 | 0.8 | 2.4 | 3.1 | 2.0 | 1.3 | 2.8 | 2.4 | 1.5 | 0.3 | 1.0 | 0.9 | 0.8 | 1.5 | 2.8 | - |
EV (Enterprise Value) |
159 B | 104 B | 63.8 B | 51.3 B | 50.7 B | 40.4 B | 50.9 B | 43.2 B | 34.3 B | 36.9 B | 35.2 B | 36.2 B | 27 B | 22.1 B | 17.3 B | 9.99 B | 6.51 B | 4.48 B | -30.3 M |
EBITDA per Share |
3.13 | 2.71 | 2.72 | 2.84 | 2.44 | 2.5 | 4.25 | 4.24 | 4.21 | 4.71 | 4.54 | 4.27 | 3.98 | 3.37 | 5.14 | 1.59 | 1.44 | 1.74 | - |
EV/EBITDA |
76.2 | 63.5 | 45.6 | 39.1 | 48.7 | 36.5 | 28.6 | 26.3 | 21.3 | 21.1 | 21.7 | 27.0 | 23.8 | 28.5 | 18.9 | 49.3 | 39.5 | 27.5 | - |
PEG |
29.96 | -14.64 | -22.71 | -47.9 | -8.82 | -2.78 | 0.54 | 0.83 | -0.83 | 1.08 | 0.4 | 0.27 | -2.31 | -2.27 | 0.92 | - | - | - | - |
P/B |
3.2 | 2.7 | 1.8 | 1.7 | 1.8 | 1.6 | 2.1 | 1.8 | 1.4 | 1.6 | 1.4 | 1.9 | 1.3 | 1.3 | 1.4 | 1.1 | 1.0 | - | - |
P/CF |
48.5 | 39.3 | 30.1 | 26.6 | 27.6 | 19.9 | 28.4 | 21.7 | 18.2 | 16.9 | 18.3 | 25.0 | 18.5 | 17.3 | -2.3 | 14.8 | 10.5 | 12.5 | - |
ROE % |
2.22 | 2.98 | 1.34 | 0.70 | 2.01 | 6.15 | 7.47 | 5.16 | 3.50 | 7.05 | 5.82 | 3.80 | 1.23 | 2.83 | 2.98 | 2.79 | 5.09 | 8.75 | - |
ROA % |
1.39 | 1.86 | 0.77 | 0.37 | 1.07 | 3.20 | 3.69 | 2.65 | 1.87 | 3.73 | 3.04 | 2.05 | 0.63 | 1.52 | 1.46 | 1.36 | 3.04 | - | - |
ROCE % |
- | - | - | - | - | - | 2.22 | 2.25 | 2.37 | 2.87 | 2.74 | 1.90 | 1.05 | 1.25 | 3.26 | - | - | - | - |
Current Ratio |
2.8 | 2.8 | 2.5 | 2.3 | 2.2 | 2.1 | 0.7 | 0.8 | 1.0 | 1.6 | 1.5 | 2.7 | 1.4 | 5.3 | 1.7 | 2.0 | 2.5 | - | - |
DSO |
8.0 | 12.6 | 17.0 | 16.0 | 17.9 | 22.9 | 106.9 | 108.2 | 117.0 | 153.2 | 182.6 | 121.3 | 112.4 | 262.5 | 97.7 | - | - | - | - |
Operating Cycle |
8.0 | 12.6 | 17.0 | 16.0 | 17.9 | 22.9 | 106.9 | 108.2 | 117.0 | 153.2 | 182.6 | 121.3 | 112.4 | 262.5 | 97.7 | - | - | - | - |
Cash Conversion Cycle |
8.0 | 12.6 | 17.0 | 16.0 | 17.9 | 22.9 | 106.9 | 108.2 | 117.0 | 153.2 | 182.6 | 121.3 | 112.4 | 262.5 | 97.7 | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Financial Ratios Welltower
| 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
1.04 | - | 0.42 | 0.46 | 0.4 | - | 0.74 | 0.42 | 0.22 | - | 0.24 | 0.21 | 0.05 | - | -0.01 | 0.2 | 0.14 | - | 0.42 | 0.06 | 0.17 | 0.39 | 0.78 | 0.43 | 0.76 | 0.55 | 1.46 | 0.34 | 0.72 | 0.27 | 0.17 | 0.42 | 1.18 | -0.31 | 0.2 | 0.51 | 0.86 | 0.92 | 0.93 | 0.55 | 0.42 | 0.38 | 0.52 | 0.89 | 0.57 | 0.58 | 0.44 | 0.24 | 0.17 | 0.04 | 0.07 | -0.03 | 0.21 | 0.35 | 0.17 | 0.26 | 0.2 | 0.15 | 0.21 | 0.4 | 0.15 | 0.01 | 0.37 |
EBITDA per Share |
0.89 | - | 0.76 | 0.75 | 0.76 | - | 0.66 | 0.64 | 0.64 | - | 0.65 | 0.69 | 0.69 | - | 0.76 | 0.68 | 0.68 | - | 0.63 | 0.58 | 0.59 | - | 0.61 | 0.64 | 0.67 | - | 0.67 | 0.61 | 0.62 | - | 1.9 | 1.25 | 0.61 | - | 1.85 | 1.24 | 0.63 | - | 1.88 | 1.28 | 0.64 | - | 1.72 | 1.13 | 0.56 | - | 2.09 | 1.51 | 806 | - | 2.2 | 1.42 | 0.72 | - | 1.75 | 1.22 | 0.64 | - | 1.7 | 1.05 | 0.48 | 1.12 | 0.74 |
ROE % |
4.04 | 2.33 | 3.83 | 3.99 | 3.61 | 2.86 | 3.43 | 2.41 | 1.66 | 1.19 | 1.18 | 1.10 | 0.96 | 0.83 | 1.96 | 2.24 | 2.18 | 1.83 | 2.80 | 4.15 | 4.87 | 6.50 | 6.98 | 8.67 | 8.64 | 8.46 | 7.71 | 4.12 | 4.30 | 5.51 | 4.05 | 4.09 | 4.36 | 3.60 | 6.62 | 8.40 | 8.41 | 7.19 | 5.85 | 4.82 | 5.66 | 5.98 | 6.50 | 6.29 | 4.69 | 3.75 | 2.42 | 1.56 | 0.95 | 1.09 | 1.87 | 2.10 | 2.79 | 2.73 | 2.23 | 2.46 | 2.93 | 2.81 | 2.57 | 3.18 | 0.45 | 0.14 | 1.37 |
ROA % |
2.62 | 1.50 | 2.44 | 2.53 | 2.28 | 1.80 | 2.12 | 1.46 | 0.96 | 0.66 | 0.92 | 0.79 | 1.09 | 1.02 | 1.02 | 1.16 | 1.11 | 0.93 | 1.43 | 2.08 | 2.43 | 3.22 | 3.39 | 4.12 | 4.08 | 3.94 | 3.60 | 1.94 | 2.04 | 2.66 | 1.92 | 1.97 | 2.14 | 1.86 | 3.41 | 4.32 | 4.32 | 3.69 | 2.99 | 2.45 | 2.86 | 3.00 | 3.30 | 3.23 | 2.44 | 1.98 | 1.27 | 0.81 | 0.49 | 0.54 | 0.95 | 1.08 | 1.45 | 1.44 | 1.16 | 1.24 | 1.43 | 1.34 | 1.23 | 1.59 | 0.21 | 0.07 | 0.72 |
Current Ratio |
3.0 | 2.8 | 3.0 | 2.9 | 2.9 | 2.8 | 2.7 | 2.9 | 2.8 | 2.5 | 2.3 | 2.2 | 2.3 | 2.3 | - | 2.2 | 2.2 | 2.2 | 2.2 | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 | 2.0 | 2.0 | 2.0 | 2.0 | 2.1 | 2.1 | 2.1 | 2.1 | 2.2 | 2.2 | 2.2 | 2.2 | 2.2 | 2.2 | 2.2 | 2.2 | 2.1 | 2.1 | 2.1 | 2.1 | 2.2 | 2.2 | 2.2 | 2.2 | 2.0 | 2.0 | 2.0 | 2.0 | 2.2 | 2.2 | 2.2 | 2.2 | 2.0 | 2.0 | 2.0 | 2.0 | 2.1 | 2.1 |
DSO |
7.3 | - | 14.2 | 8.1 | 8.4 | - | 13.2 | 17.1 | 16.4 | - | 16.7 | 16.3 | 17.1 | - | 8.0 | 15.4 | 15.1 | - | 15.1 | 17.6 | 20.9 | 19.5 | 21.1 | 18.4 | 20.9 | 24.3 | 24.3 | 23.3 | 22.2 | 10.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
7.3 | - | - | 8.1 | 8.4 | - | 13.2 | 17.1 | 16.4 | - | 16.7 | 16.3 | 17.1 | - | 8.0 | 15.4 | 15.1 | - | 15.1 | 17.6 | 20.9 | 19.5 | 21.1 | 18.4 | 20.9 | 24.3 | 24.3 | 23.3 | 22.2 | 10.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
7.3 | - | - | 8.1 | 8.4 | - | 13.2 | 17.1 | 16.4 | - | 16.7 | 16.3 | 17.1 | - | 8.0 | 15.4 | 15.1 | - | 15.1 | 17.6 | 20.9 | 19.5 | 21.1 | 18.4 | 20.9 | 24.3 | 24.3 | 23.3 | 22.2 | 10.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Multiples are an important financial analysis tool for the company Welltower , allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Financial Ratios of other stocks in the Reit healthcare industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
LTC Properties
LTC
|
$ 42.19 | -1.59 % | $ 1.95 B |  USA |
 |
National Health Investors
NHI
|
$ 64.92 | -2.2 % | $ 3.04 B | USA |
 |
Ventas
VTR
|
$ 85.38 | -1.28 % | $ 38.9 B | USA |
 |
Omega Healthcare Investors
OHI
|
$ 44.45 | -2.44 % | $ 13 B | USA |
 |
Sabra Health Care REIT
SBRA
|
$ 18.9 | -2.68 % | $ 4.56 B | USA |
 |
The GEO Group
GEO
|
$ 27.64 | -1.18 % | $ 3.8 B | USA |
 |
Global Medical REIT
GMRE
|
- | - | $ 2.37 B | USA |
 |
Healthpeak Properties
PEAK
|
- | 2.09 % | $ 9.35 B | USA |